Net Loss Per Share of Common Stock

9 Months Ended

Sep. 30, 2023

The table below summarizes the computation of basic and diluted net loss per share:


	Three Months Ended September 30,				Nine Months Ended September 30,
	2023		2022		2023		2022
	(in thousands, except share and per share data)
Net loss	$	(10,022)	$	(14,158)	$	(32,353)	$	(50,081)

Weighted-average shares used to compute basic and diluted net loss per share	40,265,520		34,356,850		37,702,207		34,069,357

Net loss per share, basic and diluted	$	(0.25)	$	(0.41)	$	(0.86)	$	(1.47)

Because the Company has reported a net loss in all periods presented, outstanding stock options, restricted stock units, ESPP purchase rights and common stock warrants are anti-dilutive and therefore diluted net loss per common share is the same as basic net loss per common share for the periods presented. The following anti-dilutive common stock equivalents were excluded from the computation of diluted net loss per share for the periods presented:


	Three Months Ended September 30,		Nine Months Ended September 30,
	2023	2022	2023	2022
Stock options	1,216,841	1,921,065	1,216,841	1,921,065
Restricted stock units	2,501,207	2,182,030	2,501,207	2,182,030

ESPP purchase rights	38,727	59,688	38,727	59,688
Common stock warrants	85,139	118,122	85,139	118,122
	3,841,914	4,280,905	3,841,914	4,280,905